Biopharmaceutical, Inc.
1Patents
1Active
1Granted
52Portfolio score
Filing activity: Jul 1, 2022 → Jul 1, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12209117B2 | Monoclonal antibodies and cocktails for treatment of Ebola infections | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.